About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.Stay Connected
My Profile
I am an authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; and counselor in issues and crisis management. I am a frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!About This Blog
Eye on FDA is published by Mark Senak of FleishmanHillard’s New York office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of FleishmanHillard or its clients.
Posts by Date
May 2024 M T W T F S S 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Twitter List
Legislative Tracking Tools
Category Archives: New and Social Media
Hey – It’s TWANK Time Again!
Remember TWANK? In February 2011 I wrote a posting on Twitter Rankings and Pharma. Twitter Rank = TWANK. The ranking provided companies, names of feeds, number of followers and KLOUT score, among other things. At the time I found 114 … Continue reading
Posted in New and Social Media
3 Comments
Twitter Has Changed the News – What it Means for Pharma
Today Mashable carried a posting that quoted Dick Costolo, CEO of Twitter, as postulating that the election of 2012 would be the “Twitter Election“. Even people who do not participate in Twitter will likely have seen articles regarding trends in … Continue reading
Posted in New and Social Media
1 Comment
Patience Patients – Are e-Patients Waiting for e-Docs?
Every so often when I have giving a talk on social media I ask the audience how many of them are on Facebook. Usually nearly everyone in the audience raises a hand. Then I ask how many of them … Continue reading
Posted in New and Social Media
3 Comments
FDA Needs to Be Clear About Social Media
After an extended Thanksgiving break, there has been time to contemplate the upcoming end of the year. Two and a half years ago, the FDA stated that “it was not the medium, it was the message” to sum up its … Continue reading
Posted in FDA Image, FDA Policy, New and Social Media
11 Comments
Will Pharma Embrace Google+?
The twittersphere was aflutter with the news yesterday that Google+ was now set up for branded pages. Until now, Google+ was set up for individuals to use, but companies not so much. For example, if a company went to set … Continue reading
Posted in New and Social Media
2 Comments